Man Group
IOVA icon

Man Group’s Iovance Biotherapeutics IOVA Stock Holding History

Man Group’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$257K Buy
73,082
+18,561
+34% +$59.4K ﹤0.01% 2241
2025
Q4 		$149K Buy
54,521
+3,118
+6% +$7.21K ﹤0.01% 2162
2025
Q3 		$112K Buy
+51,403
New +$121K ﹤0.01% 2150
2025
Q2 		– Sell
-37,758
Closed -$126K – 2277
2025
Q1 		$126K Sell
37,758
-2,377,238
-98% -$12.3M ﹤0.01% 2096
2024
Q4 		$17.9M Buy
+2,414,996
New +$22.4M 0.05% 471
2024
Q2 		– Sell
-80,583
Closed -$1.19M – 2135
2024
Q1 		$1.19M Buy
80,583
+68,964
+594% +$803K ﹤0.01% 1477
2023
Q4 		$94.5K Buy
+11,619
New +$60.8K ﹤0.01% 1988
2023
Q3 		– Sell
-91,301
Closed -$596K – 1620
2023
Q2 		$643K Buy
+91,301
New +$653K ﹤0.01% 1512
2023
Q1 		– Sell
-49,104
Closed -$339K – 1355
2022
Q4 		$314K Buy
49,104
+31,159
+174% +$243K ﹤0.01% 1638
2022
Q3 		$172K Buy
+17,945
New +$207K ﹤0.01% 1792
2022
Q2 		– Hold
0
– – – 1819
2020
Q3 		– Sell
-235,704
Closed -$6.47M – 1827
2020
Q2 		$6.47M Buy
235,704
+217,854
+1,220% +$7.16M 0.03% 553
2020
Q1 		$534K Sell
17,850
-14,068
-44% -$373K ﹤0.01% 1268
2019
Q4 		$883K Sell
31,918
-50,365
-61% -$1.15M ﹤0.01% 1513
2019
Q3 		$1.5M Buy
+82,283
New +$1.82M 0.01% 1335

Other funds holding IOVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Man Group's IOVA Position: Q1 2026 in Review

Man Group increased its Iovance Biotherapeutics (IOVA) stake by 34% in Q1 2026, buying an estimated $59.4K and bringing the position to 73,082 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #2241.

Man Group first reported a position in IOVA in Q3 2019 and has held it in 14 quarters since. The position peaked at $17.9M in Q4 2024. 285 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

  • Man Group held 73,082 shares of Iovance Biotherapeutics worth $257K as of Q1 2026.
  • Man Group bought 18,561 Iovance Biotherapeutics shares in Q1 2026, an estimated $59.4K.
  • Iovance Biotherapeutics made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #2241 holding.
  • Man Group first reported a position in Iovance Biotherapeutics in Q3 2019 and has held it in 14 quarters since.
  • Man Group's Iovance Biotherapeutics position peaked at $17.9M in Q4 2024.
  • 285 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.